Adjusted EBITDA: $22 million, an increase of $16 million year-over-year, with a margin of 19%. Cash and Cash Equivalents: $98.3 million at the end of the quarter. Operating Cash Flow: $14.8 million, ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...

In the ever-evolving landscape of human resources, where professionals play a pivotal role in organizational success, investing in one's career is essential. One significant avenue for HR ...

Phreesia (NYSE:PHR), a developer of patient intake management software, rose on Wednesday after Mizuho launched its coverage with an Outperform recommendation, citing potential in the company’s ...

Mark Douglas Smith, a director at $PHR, sold 7,000 shares of the company on 07-02-2025 for an estimated $203,000. We received data on the trade from a recent SEC ...

Q2 EBITDA guidance was raised by $2 million, roughly matching the quarterly performance beat. Needham lifts price target to $35; Piper Sandler raises target to $34. See the trading strategy with a ...